Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2009 1
2010 2
2011 1
2012 6
2013 6
2014 1
2015 2
2016 5
2017 5
2018 5
2019 4
2020 5
2021 9
2022 10
2023 11
2024 12
2025 13
2026 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

91 results

Results by year

Filters applied: . Clear all
Page 1
Genotypic and phenotypic characterisation of respiratory syncytial virus after nirsevimab breakthrough infections: a large, multicentre, observational, real-world study.
Fourati S, Reslan A, Bourret J, Casalegno JS, Rahou Y, Chollet L, Pillet S, Tremeaux P, Dossou NC, Gault E, Salmona M, Imbert-Marcille BM, Mirand A, Larrat S, Moisan A, Marot S, Schnuriger A, Veyrenche N, Engelmann I, Handala L, Henry A, Stephan V, Brichler S, Avettand-Fenoel V, Zemali N, Lefeuvre C, Pronier C, Deroche L, Jaffar-Bandjee MC, Mouna L, Francois C, Regueme A, Hartard C, Rogez S, Gallais F, Ly A, Rodriguez C, Dos Santos G, Simon-Loriere E, Schwartz O, Buchrieser J, Pawlotsky JM, Lemoine F, Audureau E, Rameix-Welti MA; POLYRES investigators. Fourati S, et al. Among authors: brichler s. Lancet Infect Dis. 2025 Mar;25(3):301-311. doi: 10.1016/S1473-3099(24)00570-X. Epub 2024 Oct 14. Lancet Infect Dis. 2025. PMID: 39419046
Effect of Peg-IFN on the viral kinetics of patients with HDV infection treated with bulevirtide.
El Messaoudi S, Brichler S, Fougerou-Leurent C, Gordien E, Gerber A, Kortebi A, Lagadic G, Subic-Levrero M, Metivier S, Pol S, Minello A, Ratziu V, Leroy V, Mathurin P, Alric L, Coulibaly F, Pawlotsky JM, Zoulim F, de Lédinghen V, Guedj J; ANRS HD EP01 BULEDELTA Study Group. El Messaoudi S, et al. Among authors: brichler s. JHEP Rep. 2024 Mar 24;6(8):101070. doi: 10.1016/j.jhepr.2024.101070. eCollection 2024 Aug. JHEP Rep. 2024. PMID: 39100818 Free PMC article.
Cryptic circulation of chikungunya virus in Côte d'Ivoire revealed by sentinel travellers, 2023-24.
Pezzi L, Modenesi G, Ayhan N, Verdurme L, Brichler S, Mansuy JM, Izopet J, Mailhe M, Lariven S, Duvignaud A, Zemali N, Ramière C, Icard V, Bravy V, Fournet N, Idrissi A, Zhu-Soubise A, Piorkowski G, Amaral R, Carrara M, Fontaine A, Tarantola A, Grard G, Durand GA, Fournier L, Paty MC, de Lamballerie X, Klitting R. Pezzi L, et al. Among authors: brichler s. J Travel Med. 2025 Oct 1;32(6):taaf002. doi: 10.1093/jtm/taaf002. J Travel Med. 2025. PMID: 39791250 Free PMC article.
COVID-19 associated pulmonary aspergillosis in critically-ill patients: a prospective multicenter study in the era of Delta and Omicron variants.
Bay P, Audureau E, Préau S, Favory R, Guigon A, Heming N, Gault E, Pham T, Chaghouri A, Turpin M, Morand-Joubert L, Jochmans S, Pitsch A, Meireles S, Contou D, Henry A, Joseph A, Chaix ML, Uhel F, Roux D, Descamps D, Emery M, Garcia-Sanchez C, Levy D, Burrel S, Mayaux J, Kimmoun A, Hartard C, Pène F, Rozenberg F, Gaudry S, Brichler S, Guillon A, Handala L, Tamion F, Moisan A, Daix T, Hantz S, Delamaire F, Thibault V, Souweine B, Henquell C, Picard L, Botterel F, Rodriguez C, Mekontso Dessap A, Pawlotsky JM, Fourati S, de Prost N; SEVARVIR investigators. Bay P, et al. Among authors: brichler s. Ann Intensive Care. 2024 Apr 24;14(1):65. doi: 10.1186/s13613-024-01296-0. Ann Intensive Care. 2024. PMID: 38658426 Free PMC article.
Clinical phenotypes and outcomes associated with SARS-CoV-2 Omicron sublineage JN.1 in critically ill COVID-19 patients: a prospective, multicenter cohort study in France, November 2022 to January 2024.
de Prost N, Audureau E, Guillon A, Handala L, Préau S, Guigon A, Uhel F, Le Hingrat Q, Delamaire F, Grolhier C, Tamion F, Moisan A, Darreau C, Thomin J, Contou D, Henry A, Daix T, Hantz S, Saccheri C, Giordanengo V, Pham T, Chaghouri A, Bay P, Pawlotsky JM, Fourati S; SEVARVIR investigators. de Prost N, et al. Ann Intensive Care. 2024 Jun 28;14(1):101. doi: 10.1186/s13613-024-01319-w. Ann Intensive Care. 2024. PMID: 38940865 Free PMC article.
A universal point-of-care immunochromatographic test for the serodiagnosis of hepatitis D.
Lopes TB, Coelho FF, Roca TP, Oliveira JKA, Delagarde V, Brichler S, Gómez Mendoza DP, Villalobos Salcedo JM, Vieira DS, Le Gal F, Gazzinelli RT, Fernandes AP. Lopes TB, et al. Among authors: brichler s. J Clin Microbiol. 2025 May 14;63(5):e0199924. doi: 10.1128/jcm.01999-24. Epub 2025 Apr 11. J Clin Microbiol. 2025. PMID: 40214253 Free PMC article.
Safety and efficacy of REP 2139-Mg in patients with HDV-related advanced liver disease in an international compassionate access program.
Stern C, Loustaud-Ratti V, Yurdaydin C, Brancaccio G, Jachs M, Reiberger T, Bardou-Jacquet E, Metivier S, Alric L, Colombain L, Meszaros M, Mathurin P, Yardeni D, Etzion O, Neumann-Haefelin C, Douglas M, Poulin S, Bazinet M, Metin RO, Vitale A, Gaeta GB, Schwarz M, Ben-Ali S, Bedoya JU, Testoni B, Zoulim F, Plissonnier ML, Levrero M, Paradis V, Francois S, de Freitas C, Kaysin F, Lecomte L, Morvan C, Schramko J, Bondezi K, Baril MÉ, Brichler S, Gerber A, Gordien E, Mackiewicz V, Dahari H, Svicher V, Chevaliez S, Vaillant A, Bourliere M. Stern C, et al. Among authors: brichler s. J Hepatol. 2026 Mar;84(3):531-542. doi: 10.1016/j.jhep.2025.10.029. Epub 2025 Nov 6. J Hepatol. 2026. PMID: 41205755
91 results